Hideki Nakanishi

Dr. Hideki Nakanishi


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
ZLZijie Li
Zijie Li
YLYi Li
Yi Li
SDShenglin Duan
Shenglin Duan
JLJia Liu
Jia Liu
PYPeng Yuan
Peng Yuan
XGXiao-Dong Gao
Xiao-Dong Gao
Saccharomyces cerevisiae spores are dormant cells, which can tolerate various types of environmental stress. In our previous work, we successfully developed biological and chemical methods for enzyme immobilization based on the structures of S. cerevisiae spore wall. In this study, we employed biological and chemical approaches for the immobilization of d-xylose isomerase (XI) from Thermus thermophilus and d-psicose 3-epimerase (DPEase) from Agrobacterium tumefaciens with yeast spores, respectively. The enzymatic properties of both immobilized XI and DPEase were characterized and the immobilized enzymes exhibit higher thermostability, broader pH tolerance, and good repeatability compared with free enzymes. Furthermore, we established a two-step approach for the bioconversion of d-glucose to d-psicose using immobilized enzymes. To improve the conversion yield, a multi-pot strategy was adopted for d-psicose production by repeating the two-step process continually. As a result, the yield of d-psicose was obviously improved and the highest yield reached about 12.0 %.

1 September 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Huijie ZhangHuijie Zhang
Huijie Zhang
SFShini Feng
Shini Feng
TYTing Yan
Ting Yan
DHDandi Huang
Dandi Huang
CZChunyi Zhi
Chunyi Zhi
XGXiao-Dong Gao
Xiao-Dong Gao
With its unique physical and chemical properties and structural similarity to carbon, boron nitride (BN) has attracted considerable attention and found many applications. Biomedical applications of BN have recently started to emerge, raising great hopes in drug and gene delivery. Here, we developed a targeted anticancer drug delivery system based on folate-conjugated BN nanospheres (BNNS) with receptor-mediated targeting. Folic acid (FA) was successfully grafted onto BNNS via esterification reaction. In vitro cytotoxicity assay showed that BNNS-FA complexes were non-toxic to HeLa cells up to a concentration of 100 µg/mL. Then, doxorubicin hydrochloride (DOX), a commonly used anticancer drug, was loaded onto BNNS-FA complexes. BNNS-FA/DOX complexes were stable at pH 7.4 but effectively released DOX at pH 5.0, which exhibited a pH sensitive and sustained release pattern. BNNS-FA/DOX complexes could be recognized and specifically internalized by HeLa cells via FA receptor-mediated endocytosis. BNNS-FA/DOX complexes exhibited greater cytotoxicity to HeLa cells than free DOX and BNNS/DOX complexes due to the increased cellular uptake of DOX mediated by the FA receptor. Therefore, BNNS-FA complexes had strong potential for targeted cancer therapy.

1 January 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SFShini Feng
Shini Feng
Huijie ZhangHuijie Zhang
Huijie Zhang
CZChunyi Zhi
Chunyi Zhi
XGXiao-Dong Gao
Xiao-Dong Gao
HNHideki Nakanishi
Hideki Nakanishi
Background: Anticancer drug-delivery systems (DDSs) capable of responding to the physiological stimuli and efficiently releasing drugs inside tumor cells are highly desirable for effective cancer therapy. Herein, pH-responsive, charge-reversal poly(allylamine hydrochlorid)-citraconic anhydride (PAH-cit) functionalized boron nitride nanospheres (BNNS) were fabricated and used as a carrier for the delivery and controlled release of doxorubicin (DOX) into cancer cells. Methods: BNNS was synthesized through a chemical vapor deposition method and then functionalized with synthesized charge-reversal PAH-cit polymer. DOX@PAH-cit–BNNS complexes were prepared via step-by-step electrostatic interactions and were fully characterized. The cellular uptake of DOX@PAH-cit–BNNS complexes and DOX release inside cancer cells were visualized by confocal laser scanning microscopy. The in vitro anticancer activity of DOX@PAH-cit–BNNS was examined using CCK-8 and live/dead viability/cytotoxicity assay. Results: The PAH-cit–BNNS complexes were nontoxic to normal and cancer cells up to a concentration of 100 µg/mL. DOX was loaded on PAH-cit–BNNS complexes with high efficiency. In a neutral environment, the DOX@PAH-cit–BNNS was stable, whereas the loaded DOX was effectively released from these complexes at low pH condition due to amide hydrolysis of PAH-cit. Enhanced cellular uptake of DOX@PAH-cit–BNNS complexes and DOX release in the nucleus of cancer cells were revealed by confocal microscopy. Additionally, the effective delivery and release of DOX into the nucleus of cancer cells led to high therapeutic efficiency. Conclusion: Our findings indicated that the newly developed PAH-cit–BNNS complexes are promising as an efficient pH-responsive DDS for cancer therapy.

1 March 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
SFShini Feng
Shini Feng
Huijie ZhangHuijie Zhang
Huijie Zhang
SXSha Xu
Sha Xu
CZChunyi Zhi
Chunyi Zhi
HNHideki Nakanishi
Hideki Nakanishi
XGXiao-Dong Gao
Xiao-Dong Gao

1 January 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SLSheng-Tao Li
Sheng-Tao Li
NWNing Wang
Ning Wang
SXSha Xu
Sha Xu
JYJian Yin
Jian Yin
HNHideki Nakanishi
Hideki Nakanishi
XGXiao-Dong Gao
Xiao-Dong Gao

1 October 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GLGun-Hee Lee
Gun-Hee Lee
MFMorihisa Fujita
Morihisa Fujita
HNHideki Nakanishi
Hideki Nakanishi
HMHaruhiko Miyata
Haruhiko Miyata
MIMasahito Ikawa
Masahito Ikawa
TKTaroh Kinoshita
Taroh Kinoshita
PGAP6, also known as TMEM8A, is a phospholipase A2 with specificity to glycosylphosphatidylinositol (GPI) and expressed on the surface of various cells. CRIPTO, a GPI-anchored co-receptor for a morphogenic factor Nodal, is a sensitive substrate of PGAP6. PGAP6-mediated shedding of CRIPTO plays a critical role in an early stage of embryogenesis. In contrast, CRYPTIC, a close family member of CRIPTO, is resistant to PGAP6. In this report, chimeras between CRIPTO and CRYPTIC and truncate mutants of PGAP6 were used to demonstrate that the CFC (Cripto-1/FRL1/Cryptic) domain of CRIPTO is recognized by an N-terminal domain of PGAP6 for processing. We also report that among 56 human GPI-anchored proteins tested, only glypican 3, prostasin, SPACA4 and contactin-1 in addition to CRIPTO are sensitive to PGAP6, indicating that PGAP6 has a narrow specificity toward various GPI-anchored proteins.